Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Touyun Biotech Group's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was -56.05%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Touyun Biotech Group's 3-Year ROIIC % or its related term are showing as below:
HKSE:01332's 3-Year ROIIC % is ranked worse than 90% of 390
companies
in the Packaging & Containers industry
Industry Median: 1.56
vs HKSE:01332: -56.05
Touyun Biotech Group (HKSE:01332) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Touyun Biotech Group 3-Year ROIIC % Related Terms
Touyun Biotech Group 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Touyun Biotech Group's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01332 vs SW, AMCR, PKG: 3-Year ROIIC % Comparison
For the Packaging & Containers subindustry, Touyun Biotech Group's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Touyun Biotech Group 3-Year ROIIC % vs Packaging & Containers Industry
For the Packaging & Containers industry and Consumer Cyclical sector, Touyun Biotech Group's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Touyun Biotech Group's 3-Year ROIIC % falls into.
Touyun Biotech Group's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -130.088977 (Dec. 2025) - -39.73 (Dec. 2022) )
/
( 960.386 (Dec. 2025) - 799.187 (Dec. 2022) )
=
-90.358977
/
161.199
=
-56.05%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Touyun Biotech Group (HKSE:01332) has a 3-Year ROIIC % of -56.05 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Touyun Biotech Group and its competitors. According to the industry distribution chart, Touyun Biotech Group ranks #351 out of 390 companies in the Packaging & Containers industry, placing it in the top 90%.
Is Touyun Biotech Group's 3-Year ROIIC % too high?
Touyun Biotech Group's current 3-Year ROIIC % is -56.05. Based on the distribution chart, Touyun Biotech Group ranks #351 out of 390 companies in the Packaging & Containers industry, which is in the bottom quartile relative to peers. Overall, Touyun Biotech Group has a GF Score™ of 28/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Touyun Biotech Group's 3-Year ROIIC % compare to SW and AMCR?
According to the Packaging & Containers industry distribution chart, Touyun Biotech Group ranks #351 out of 390 companies for 3-Year ROIIC %. This places Touyun Biotech Group in the lower half of its industry. The industry median 3-Year ROIIC % is 1.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Packaging & Containers company?
The median 3-Year ROIIC % among Packaging & Containers companies is 1.56, based on 390 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Touyun Biotech Group and its competitors. For the Packaging & Containers industry, the median 3-Year ROIIC % is 1.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Touyun Biotech Group's current 3-Year ROIIC % is -56.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Touyun Biotech Group stock overvalued right now?
Based on GuruFocus' analysis, Touyun Biotech Group (HKSE:01332) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.16, compared to a current price of HK$0.16 — trading 3.1% below its estimated fair value. The current 3-Year ROIIC % is -56.05. Touyun Biotech Group's overall GF Score™ is 28/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Touyun Biotech Group (HKSE:01332), the current 3-Year ROIIC % is -56.05 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Touyun Biotech Group (HKSE:01332) Overvalued in 2026?
Based on GuruFocus' analysis, Touyun Biotech Group stock appears to be undervalued.
The current stock price of HK$0.16 is trading 3.1% below its estimated GF Value™ of HK$0.16.
GuruFocus considers Touyun Biotech Group to be Fairly Valued.
Key valuation signals for HKSE:01332:
3-Year ROIIC %: -56.05
GF Value™: HK$0.16 vs. price of HK$0.16 (3.1% below fair value)
No single metric tells the full story. See the HKSE:01332 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Touyun Biotech Group Ltd is principally engaged in the (i) the manufacture and sale of packaging products; (ii) investments and trading in securities and money lending, and (iii) production and sale of Chlamydomonas reinhardtii, micro-algae and related products. The company generates majority of its revenue from packaging products segment.
28GF Score
Get the complete analysis for HKSE:01332
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01332 has been successfully added to your 
